275 research outputs found
Strategies to increase the resectability of hepatocellular carcinoma
© 2015 Baishideng Publishing Group Inc. Hepatocellular carcinoma (HCC) is best treated by liver transplantation, but the applicability of transplantation is greatly limited. Tumor resection in partial hepatectomy is hence resorted to. However, in most parts of the world, only 20%-30% of HCCs are resectable. The main reason for such a low resectability is a future liver remnant too small to be sufficient for the patient. To allow more HCC patients to undergo curative hepatectomy, a variety of ways have been developed to increase the resectability of HCC, mainly ways to increase the future liver remnants in patients through hypertrophy. They include portal vein embolization, sequential transarterial chemoembolization and portal vein embolization, staged hepatectomy, two-staged hepatectomy with portal vein ligation, and Associating Liver Partition and Portal Vein Ligation in Staged Hepatectomy. Herein we review, describe and evaluate these different ways, ways that can be life-saving.published_or_final_versio
Importance of surgical margin in the outcomes of hepatocholangiocarcinoma
published_or_final_versio
An extra-adrenal pheochromocytoma mimicking a primary liver cancer
published_or_final_versio
Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS
published_or_final_versio
Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma - an immunohistochemical study
published_or_final_versio
Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016
published_or_final_versio
Media coverage of liver transplant events promotes donations from the deceased
Commentarypublished_or_final_versio
- …